Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 961 AL 975

Inflammation in Neurological Disorders: The Thin Boundary Between Brain and Periphery

Cervellati C, Trentini A, Pecorelli A, Valacchi G.

Antioxid Redox Signal. 2020 Jul 20;33(3):191-210. doi: 10.1089/ars.2020.8076. Epub 2020 Apr 9.

Initiation and propagation of α-synuclein aggregation in the nervous system

Hijaz BA, Volpicelli-Daley LA.

Mol Neurodegener. 2020 Mar 6;15(1):19. doi: 10.1186/s13024-020-00368-6.

Analysis of DNA methylation associates the cystine-glutamate antiporter SLC7A11 with risk of Parkinson's disease

Vallerga CL, Zhang F, Fowdar J, McRae AF, Qi T, Nabais MF, Zhang Q, Kassam I, Henders AK, Wallace L, Montgomery G, Chuang YH, Horvath S, Ritz B, Halliday G, Hickie I, Kwok JB, Pearson J, Pitcher T, Kennedy M, Bentley SR, Silburn PA, Yang J, Wray NR, Lewis SJG, Anderson T, Dalrymple-Alford J, Mellick GD, Visscher PM, Gratten J.

Nat Commun. 2020 Mar 6;11(1):1238. doi: 10.1038/s41467-020-15065-7.

Angiogenin and tRNA fragments in Parkinson's disease and neurodegeneration

Prehn JHM, Jirström E.

Acta Pharmacol Sin. 2020 Apr;41(4):442-446. doi: 10.1038/s41401-020-0375-9. Epub 2020 Mar 6.

Central auditory processing in parkinsonian disorders: A systematic review

De Groote E, De Keyser K, Bockstael A, Botteldooren D, Santens P, De Letter M.

Neurosci Biobehav Rev. 2020 Jun;113:111-132. doi: 10.1016/j.neubiorev.2020.03.001. Epub 2020 Mar 4.

Clinicopathological co-occurrence of Fahr's disease and dementia with Lewy bodies

Jensen MP, Spasic-Boskovic O, Rowe JB, Galton C, Allinson KSJ.

Clin Neuropathol. 2020 Sep/Oct;39(5):227-231. doi: 10.5414/NP301267.

Palliative care for Parkinson's disease and related disorders: stepping into the future

Kluger BM.

Ann Palliat Med. 2020 Feb;9(Suppl 1):S3-S5. doi: 10.21037/apm.2020.02.05.

Massage therapy as a complementary treatment for Parkinson's disease: A Systematic Literature Review

Angelopoulou E, Anagnostouli M, Chrousos GP, Bougea A.

Complement Ther Med. 2020 Mar;49:102340. doi: 10.1016/j.ctim.2020.102340. Epub 2020 Feb 6.

Long-standing multiple sclerosis neurodegeneration: volumetric magnetic resonance imaging comparison to Parkinson's disease, mild cognitive impairment, Alzheimer's disease, and elderly healthy controls

Jakimovski D, Bergsland N, Dwyer MG, Hagemeier J, Ramasamy DP, Szigeti K, Guttuso T, Lichter D, Hojnacki D, Weinstock-Guttman B, Benedict RHB, Zivadinov R.

Neurobiol Aging. 2020 Jun;90:84-92. doi: 10.1016/j.neurobiolaging.2020.02.002. Epub 2020 Feb 8.

Glycogen synthase kinase-3 as a key regulator of cognitive function

Fan X, Zhao Z, Wang D, Xiao J.

Acta Biochim Biophys Sin (Shanghai). 2020 Mar 18;52(3):219-230. doi: 10.1093/abbs/gmz156.

Heme-Oxygenase-1

Facchinetti MM.

Antioxid Redox Signal. 2020 Jun 10;32(17):1239-1242. doi: 10.1089/ars.2020.8065.

Autophagy in neurodegeneration: New insights underpinning therapy for neurological diseases

Corti O, Blomgren K, Poletti A, Beart PM.

J Neurochem. 2020 Aug;154(4):354-371. doi: 10.1111/jnc.15002. Epub 2020 Apr 16.

Vulnerabilities of Aging and Biological Effects of Physical Activity Provide New Clues for Interventions in Parkinson's Disease

Bohnen NI.

J Gerontol A Biol Sci Med Sci. 2020 Mar 9;75(4):687-689. doi: 10.1093/gerona/glaa026.

PINK1/Parkin Mediated Mitophagy, Ca(2+) Signalling, and ER-Mitochondria Contacts in Parkinson's Disease

Barazzuol L, Giamogante F, Brini M, Calì T.

Int J Mol Sci. 2020 Mar 5;21(5):1772. doi: 10.3390/ijms21051772.

An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events

Cordaro M, Cuzzocrea S, Crupi R.

Antioxidants (Basel). 2020 Mar 5;9(3):216. doi: 10.3390/antiox9030216.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias